Product Information
APTIOM 400 MG TABLET is a brand product labeled by Sumitomo Pharma America, Inc., priced at $44.0400 per EA under NDC 63402020430. Its NADAC has been published 614 times since Nov 19, 2014.
FDA first approved this application on Nov 8, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ESLICARBAZEPINE ACETATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 mg/1
Manufacturer
Sumitomo Pharma America, Inc.NDC
63402020430
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ESLICARBAZEPINE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA022416FDA Approved
11/8/2013
TE Code
AB
On Market Since
4/7/2014
Pharmacological Classes
Price Statistics
The NADAC for APTIOM 400 MG TABLET has been published 614 times since Nov 19, 2014, and over the history we have for it it has risen 138.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $44.0400 per EA |
|---|---|
| All-time high | $44.3505 (Jul 15, 2026) |
| All-time low | $18.4811 (Nov 19, 2014) |
| 52-week high | $44.3505 |
| 52-week low | $42.9738 |
| Median price | $32.5074 |
| Average price | $32.9611 |
| Largest weekly change | +9.9% (Jan 10, 2018) |
| Weeks tracked | 614 |
| Tracking since | Nov 19, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ESLICARBAZEPINE ACETATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of APTIOM 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for APTIOM 400 MG TABLET, manufactured by Sumitomo Pharma America, Inc., is $44.0400 per EA (NDC 63402020430), effective Aug 19, 2026.
How has the price of APTIOM 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for APTIOM 400 MG TABLET has risen 138.3%. It has been tracked across 614 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for APTIOM 400 MG TABLET?
Since Nov 19, 2014, the NADAC for APTIOM 400 MG TABLET has ranged from a low of $18.4811 (Nov 19, 2014) to a high of $44.3505 (Jul 15, 2026), with a median of $32.5074 per EA.
Are there cheaper alternatives to APTIOM 400 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of APTIOM 400 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures APTIOM 400 MG TABLET?
APTIOM 400 MG TABLET (NDC 63402020430) is labeled by Sumitomo Pharma America, Inc., and CMS classifies it as a brand product.